Physician profile
Katherine A Bertram
NPI 1689668790
$1,190.21
in general payments reported to CMS, 2019-2025
21 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $897 · 2020: $276 · 2024: $18.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $18.03.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $18.03 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $215.95 | 2019-2020 | |
| Novartis Pharmaceuticals Corporation | $186.76 | 2019-2020 | |
| Pfizer INC. | $93.97 | 2019-2020 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $83.02 | 2019-2020 | |
| Amgen INC. | $79.19 | 2019-2020 | |
| Lilly USA, LLC | $76.61 | 2019-2020 | |
| Astellas Pharma US INC | $72.28 | 2019-2020 | |
| Glaxosmithkline, LLC. | $52.99 | 2019-2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $51.49 | 2019 | |
| Sanofi-Aventis U.S. LLC | $41.20 | 2019-2020 | |
| Sunovion Pharmaceuticals INC. | $34.98 | 2019-2020 | |
| Astrazeneca Pharmaceuticals LP | $29.81 | 2019-2020 | |
| Acadia Pharmaceuticals INC | $27.53 | 2019 | |
| Acorda Therapeutics, INC | $23.24 | 2019 | |
| Allergan, INC. | $20.51 | 2019 |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $18.03 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $18.01 | 2019 | |
| Janssen Pharmaceuticals, INC | $17.66 | 2020 | |
| Shire North American Group INC | $16.38 | 2019 | |
| Amarin Pharma, INC. | $15.85 | 2019 | |
| E.R. Squibb & Sons, L.L.C. | $14.75 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Katherine Bertram listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.